FI3687287T3 - Humanisoitua c1q-kompleksia ilmentävät jyrsijät - Google Patents

Humanisoitua c1q-kompleksia ilmentävät jyrsijät Download PDF

Info

Publication number
FI3687287T3
FI3687287T3 FIEP18786611.6T FI18786611T FI3687287T3 FI 3687287 T3 FI3687287 T3 FI 3687287T3 FI 18786611 T FI18786611 T FI 18786611T FI 3687287 T3 FI3687287 T3 FI 3687287T3
Authority
FI
Finland
Prior art keywords
polypeptide
rodent
human
nucleic acid
chimeric
Prior art date
Application number
FIEP18786611.6T
Other languages
English (en)
Finnish (fi)
Inventor
Brinda Prasad
Naxin Tu
Karolina Meagher
Lynn Macdonald
Andrew Murphy
Sean Stevens
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Application granted granted Critical
Publication of FI3687287T3 publication Critical patent/FI3687287T3/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/054—Animals comprising random inserted nucleic acids (transgenic) inducing loss of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0337—Animal models for infectious diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0368—Animal model for inflammation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0387—Animal model for diseases of the immune system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C12N2015/8527—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic for producing animal models, e.g. for tests or diseases

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FIEP18786611.6T 2017-09-29 2018-09-27 Humanisoitua c1q-kompleksia ilmentävät jyrsijät FI3687287T3 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762565438P 2017-09-29 2017-09-29
PCT/US2018/053099 WO2019067706A1 (en) 2017-09-29 2018-09-27 NON-HUMAN ANIMALS EXPRESSING A HUMANIZED C1Q COMPLEX

Publications (1)

Publication Number Publication Date
FI3687287T3 true FI3687287T3 (fi) 2023-10-12

Family

ID=63858187

Family Applications (1)

Application Number Title Priority Date Filing Date
FIEP18786611.6T FI3687287T3 (fi) 2017-09-29 2018-09-27 Humanisoitua c1q-kompleksia ilmentävät jyrsijät

Country Status (18)

Country Link
US (2) US11186848B2 (cg-RX-API-DMAC7.html)
EP (2) EP4249502A3 (cg-RX-API-DMAC7.html)
JP (2) JP7242650B2 (cg-RX-API-DMAC7.html)
KR (2) KR20240128129A (cg-RX-API-DMAC7.html)
CN (2) CN116376973A (cg-RX-API-DMAC7.html)
AU (1) AU2018341685A1 (cg-RX-API-DMAC7.html)
CA (1) CA3077418A1 (cg-RX-API-DMAC7.html)
DK (1) DK3687287T5 (cg-RX-API-DMAC7.html)
ES (1) ES2961713T3 (cg-RX-API-DMAC7.html)
FI (1) FI3687287T3 (cg-RX-API-DMAC7.html)
IL (1) IL273588A (cg-RX-API-DMAC7.html)
LT (1) LT3687287T (cg-RX-API-DMAC7.html)
PT (1) PT3687287T (cg-RX-API-DMAC7.html)
RU (1) RU2020112751A (cg-RX-API-DMAC7.html)
SG (1) SG11202002002XA (cg-RX-API-DMAC7.html)
SI (1) SI3687287T1 (cg-RX-API-DMAC7.html)
WO (1) WO2019067706A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202001389B (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019067875A1 (en) 2017-09-29 2019-04-04 Regeneron Pharmaceuticals, Inc. NON-HUMAN ANIMALS COMPRISING A HUMANIZED TTR LOCUS AND METHODS OF USE
WO2020247452A1 (en) 2019-06-04 2020-12-10 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized ttr locus with a beta-slip mutation and methods of use

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030082546A1 (en) * 1996-11-06 2003-05-01 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
DK1407017T3 (en) * 2000-11-07 2009-09-21 Zymogenetics Inc Human receptor for tumor nekrose faktor
US20040248156A1 (en) * 2001-12-03 2004-12-09 Tianhua Hu Methods and materials relating to novel C1q domain-containing polypeptides and polynucleotides
GB0322998D0 (en) * 2003-10-01 2003-11-05 Ares Trading Sa Protein
EP1802193B1 (en) 2004-10-19 2014-04-30 Regeneron Pharmaceuticals, Inc. Method for generating a mouse homozygous for a genetic modification
CN101330925A (zh) * 2005-12-16 2008-12-24 瑞泽恩制药公司 用d114拮抗剂抑制肿瘤生长的治疗方法
HRP20150086T1 (xx) * 2007-06-12 2015-02-27 Ac Immune S.A. Humanizirana antitijela za beta amiloid
PL3248462T3 (pl) * 2010-03-31 2024-07-08 Ablexis, Llc Modyfikacja myszy metodami inżynierii genetycznej w celu wytworzenia przeciwciał chimerycznych
CN103380145B (zh) * 2010-12-17 2016-10-12 生物控股有限公司 人类抗-sod1抗体
US9043996B2 (en) * 2011-10-28 2015-06-02 Regeneron Pharmaceuticals, Inc. Genetically modified major histocompatibility complex animals
KR102295746B1 (ko) * 2011-10-28 2021-09-01 리제너론 파아마슈티컬스, 인크. 유전자 변형된 주요 조직적합성 복합체 마우스
US9801362B2 (en) * 2012-03-16 2017-10-31 Regeneron Pharmaceuticals, Inc. Non-human animals expressing pH-sensitive immunoglobulin sequences
FR2996561B1 (fr) * 2012-10-09 2016-03-18 Commissariat Energie Atomique Procede de preparation de proteine c1q recombinante
MX2015010841A (es) 2013-02-20 2016-05-09 Regeneron Pharma Modificacion genetica de ratas.
DK3456831T3 (da) 2013-04-16 2021-09-06 Regeneron Pharma Målrettet modifikation af rottegenom
SG11201510316UA (en) * 2013-07-09 2016-01-28 Annexon Inc Anti-complement factor c1q antibodies and uses thereof
MX2016014504A (es) * 2014-05-05 2017-05-23 Regeneron Pharma Animales c5 y c3 humanizados.
BR112017010793A2 (pt) * 2014-11-24 2017-12-26 Regeneron Pharma animal não humano geneticamente modificado, camundongo, métodos para produzir um animal não humano geneticamente modificado e de triagem de candidatos a fármaco direcionados a um antígeno de interesse, e, modelo de camundongo.
WO2019067875A1 (en) 2017-09-29 2019-04-04 Regeneron Pharmaceuticals, Inc. NON-HUMAN ANIMALS COMPRISING A HUMANIZED TTR LOCUS AND METHODS OF USE

Also Published As

Publication number Publication date
DK3687287T3 (da) 2023-10-16
CN116376973A (zh) 2023-07-04
CN111386039A (zh) 2020-07-07
IL273588A (en) 2020-05-31
AU2018341685A1 (en) 2020-04-02
PT3687287T (pt) 2023-11-03
RU2020112751A (ru) 2021-10-29
SI3687287T1 (sl) 2023-11-30
ZA202001389B (en) 2024-01-31
EP4249502A3 (en) 2023-12-06
EP3687287A1 (en) 2020-08-05
RU2020112751A3 (cg-RX-API-DMAC7.html) 2022-02-09
DK3687287T5 (da) 2024-08-26
CN111386039B (zh) 2023-02-28
WO2019067706A1 (en) 2019-04-04
EP3687287B1 (en) 2023-07-12
US20220033847A1 (en) 2022-02-03
KR102696334B1 (ko) 2024-08-21
CA3077418A1 (en) 2019-04-04
KR20200058487A (ko) 2020-05-27
EP4249502A2 (en) 2023-09-27
US20190100772A1 (en) 2019-04-04
JP7242650B2 (ja) 2023-03-20
LT3687287T (lt) 2023-10-25
KR20240128129A (ko) 2024-08-23
JP2023075230A (ja) 2023-05-30
WO2019067706A4 (en) 2019-05-23
ES2961713T3 (es) 2024-03-13
SG11202002002XA (en) 2020-04-29
JP2020535815A (ja) 2020-12-10
JP7534465B2 (ja) 2024-08-14
US11186848B2 (en) 2021-11-30

Similar Documents

Publication Publication Date Title
KR102617691B1 (ko) 인간화 분화 클러스터 47 유전자를 가진 비인간 동물
KR102508182B1 (ko) 형질전환 대식세포, 키메라 항원 수용체, 및 관련 방법
US12594323B2 (en) Methods of reducing neuroinflammation
CA2461917A1 (en) Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods
JP2024091951A (ja) 操作された重鎖可変領域を有する齧歯類
JP7534465B2 (ja) ヒト化C1q複合体を発現する非ヒト動物
JPWO2006035741A1 (ja) Es細胞特異的発現遺伝子及びその利用
JP2005507648A5 (cg-RX-API-DMAC7.html)
Xu et al. Expressional analysis of immunoglobulin D in cattle (Bos taurus), a large domesticated ungulate
KR101972899B1 (ko) 소수성 테일 도메인이 제거된 먹장어 유래 VLRB 단백질과 C4bp 올리고머화 도메인이 연결된 융합 단백질 및 이의 용도
JP2017525368A5 (cg-RX-API-DMAC7.html)
JP2020535815A5 (cg-RX-API-DMAC7.html)
US11878065B2 (en) Reporter protein fused antibodies
US20250195614A1 (en) Method of treating pancreatic cancer
JP4892717B2 (ja) ニワトリキメラ抗体およびその利用
KR101972894B1 (ko) 소수성 테일 도메인이 제거된 먹장어 유래 vlrb 단백질에 칠성장어 유래 vlrb 단백질의 c 말단 서열이 연결된 융합 단백질 및 이의 용도
Kriz et al. Establishment of a tagged variant of Lgr4 receptor suitable for functional and expression studies in the mouse
JP6614431B2 (ja) 抗ゼブラフィッシュCD4モノクローナル抗体又は抗体フラグメント、抗ゼブラフィッシュCD8αモノクローナル抗体又は抗体フラグメント及びそれらをコードする核酸
US20260137759A1 (en) Methods of modulating circadian clock gene expression
EP4538285A1 (en) Pd-1 variant and use thereof
CN104961833A (zh) 一种人源NKp80-Fc融合蛋白及其制备方法和在肿瘤治疗中的应用
JP2024520790A5 (cg-RX-API-DMAC7.html)
WO2019189814A1 (ja) 細胞のダイレクトリプログラミング方法
TH85575A (th) สัตว์ทรานสเจนิคที่แสดงลักษณะโปรตีนที่พบร่วมกับส่วนประกอบหน่วยรับแอนโดรเจน
KR20090052974A (ko) 위의 기능에 관여하는 위 조직 특이적 유전자phs3sx00440